Trial · NCT03463993
Results by group34
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 34
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Postpartum Haemorrhage (PPH) | Group A | PPH based on Haematocrit calculation | 48 | Participants | |
| Number of Participants With Postpartum Haemorrhage (PPH) | Group B | PPH based on Haematocrit calculation | 54 | Participants | |
| Number of Participants With Postpartum Haemorrhage (PPH) | Group A | PPH based on Haemoglobin calculation | 56 | Participants | |
| Number of Participants With Postpartum Haemorrhage (PPH) | Group B | PPH based on Haemoglobin calculation | 71 | Participants | |
| Estimated Blood Loss | Group A | Visually estimated blood loss | 483.73 | Standard Deviation 182.56 | ml |
| Estimated Blood Loss | Group B | Visually estimated blood loss | 479.61 | Standard Deviation 139.49 | ml |
| Estimated Blood Loss | Group A | Haematocrit-based calculation of estimated blood loss | 650.06 | Standard Deviation 631.50 | ml |
| Estimated Blood Loss | Group B | Haematocrit-based calculation of estimated blood loss | 653.05 | Standard Deviation 796.03 | ml |
| Estimated Blood Loss | Group A | Haemoglobin-based calculation of estimated blood loss | 644.30 | Standard Deviation 692.27 | ml |
| Estimated Blood Loss | Group B | Haemoglobin-based calculation of estimated blood loss | 707.68 | Standard Deviation 948.01 | ml |
| Amount of Blood Transfused | Group A | 1.5 | Inter-Quartile Range 1 to 2 | units of blood given | |
| Amount of Blood Transfused | Group B | 2.5 | Inter-Quartile Range 2 to 3 | units of blood given | |
| Number of Participants With Use of Additional Uterotonics | Group A | 38 | Participants | ||
| Number of Participants With Use of Additional Uterotonics | Group B | 32 | Participants | ||
| Number of Participants With Tranexamic Acid Side Effects | Group A | 7 | Participants | ||
| Number of Participants With Tranexamic Acid Side Effects | Group B | 3 | Participants | ||
| Number of Participants Requiring Emergency Surgery for PPH | Group A | 0 | Participants | ||
| Number of Participants Requiring Emergency Surgery for PPH | Group B | 2 | Participants | ||
| Number of Days of Participants' Hospital Stay | Group A | 5 | Inter-Quartile Range 4 to 5 | days | |
| Number of Days of Participants' Hospital Stay | Group B | 5 | Inter-Quartile Range 4 to 5 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03463993/results